Company Overview of G1 Therapeutics, Inc.
Key Executives for G1 Therapeutics, Inc.
|Mark A. Velleca M.D., Ph.D.||12 Relationships||Chief Executive Officer, President and Director||53|
|Jennifer K. Moses||No Relationships||Vice President of Finance & Administration||42|
|Rajesh K. Malik M.D., M.B., Ch.B.||No Relationships||Chief Medical Officer||58|
|Gregory J. Mossinghoff||No Relationships||Chief Business Officer and Secretary||56|
|Terry L. Murdock MSc||No Relationships||Senior Vice President of Development Operations||--|
G1 Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Seth A. Rudnick M.D.||100 Relationships||G1 Therapeutics, Inc.||68|
|Mark A. Velleca M.D., Ph.D.||12 Relationships||G1 Therapeutics, Inc.||53|
|Christy L. Shaffer Ph.D.||104 Relationships||Hatteras Venture Partners||59|
|Glenn P. Muir||49 Relationships||ReWalk Robotics Ltd.||58|
|Kwok-Kin Wong M.D., Ph.D.||12 Relationships||NYU Langone Medical Center LLC||--|
G1 Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Glenn P. Muir||49 Relationships||3 Executives|
|Compensation Committee Ph.D.||Christy L. Shaffer||104 Relationships||3 Executives|
|Nominating Committee M.D.||Seth A. Rudnick||100 Relationships||3 Executives|
|Corporate Governance Committee M.D.||Seth A. Rudnick||100 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$538.7K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.